Feed APLAB.BO
Summary
38 / 100 · Bulios Score
Valuation 51Growth 69Profitability 10Quality 0Debt 60Stability 52
What speaks for it
- Earnings per share grew by 104% a year over the last 3 years.
What to watch
- The company made a loss over the last 12 months.
- It passes only 1 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Yes, fastRevenue (INR)
20222023202420252026
Diluted EPS (INR)
20222023202420252026
Revenue grew by 2.0% a year over 5 years. Over the last 3 years it grew by 4.3% a year. Earnings per share grew by 104% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of ₹8.51M.
Profitability in detailIs it financially healthy?
YesCash and short-term investments ₹74.6M
Debt ₹0.00
Free cash flow over 12 months ₹0.00
It has no debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail